Glucose in Dialysis Water in Non-diabetics

Phase 4

Completed

• Conditions: Renal Failure, Chronic

• Registration Number: NCT00439023
• Lead Sponsor: Regional Hospital Holstebro

Brief Summary

The purposes are

1. to measure the effect of dialysis with glucose on blood pressure, pulse rate, plasma concentration of glucose, plasma concentrations of glucagon, growth hormone, renin, angiotensin II, endothelin and body temperature, and

2. to analysis the relationship between changes in blood pressure on the one hand and changes in vasoactive hormones on the other

Detailed Description

Measurement of hormones and blood pressure during dialysis treatment.

Study Timeline

• Study Start: 2006-05
• Study First Submitted: 2007-02-20
• Study First Submitted QC: 2007-02-21
• Study First Posted: 2007-02-22
• Study Completion: 2007-05
• Status Verified: 2007-09
• Last Update Submitted: 2015-09-14
• Last Update Posted: 2015-09-15

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 18

Inclusion Criteria

1. Age > 18 years,
2. Both men and women,
3. Dialysis treatment for at least three months

Exclusion Criteria

1. Heart failure,
2. Chronic liver disease,
3. Diabetes mellitus,
4. Malignant disease,
5. Nephrotic syndrome,
6. Lack of compliance, 7 Unwillingness to participate

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: CROSSOVER

Primary Outcome Measures

Name	Time	Method
Effect of glucose in dialysis water on blood pressure, insulin and vasoactive hormones	one week

Secondary Outcome Measures

Name	Time	Method
Relationship between changes in blood pressure and changes in hormones during treatment	one week

Trial Locations

Locations (1)

Holstebro Hospital; 🇩🇰 Holstebro, Denmark